High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Open accessAbstract
It has been reported that ACE2 is the main host cell receptor of 2019-nCoV and plays a crucial role in the entry of virus into the cell to cause the final infection. To investigate the potential route of 2019-nCov infection on the mucosa of oral cavity, bulk RNA-seq profiles from two public databases including The Cancer Genome Atlas (TCGA) and Functional Annotation of The Mammalian Genome Cap Analysis of Gene Expression (FANTOM5 CAGE) dataset were collected. RNA-seq profiling data of 13 organ types with para-carcinoma normal tissues from TCGA and 14 organ types with normal tissues from FANTOM5 CAGE were analyzed in order to explore and validate the expression of ACE2 on the mucosa of oral cavity. Further, single-cell transcriptomes from an independent data generated in-house were used to identify and confirm the ACE2-expressing cell composition and proportion in oral cavity. The results demonstrated that the ACE2 expressed on the mucosa of oral cavity. Interestingly, this receptor was highly enriched in epithelial cells of tongue. Preliminarily, those findings have explained the basic mechanism that the oral cavity is a potentially high risk for 2019-nCoV infectious susceptibility and provided a piece of evidence for the future prevention strategy in dental clinical practice as well as daily life.
Verification finished with gaps
Some checks didn’t finish. The results below cover the steps that did.
- Registry recordVerified
- Full textRead the full text
- Reference list26 references found
- Reference check27 of 27 references checked
- StatisticsRecomputed
- Claims33 claims anchored to a quote
- Cited sourcesChecked
- Self-checkDidn’t finish — the rest of the report still applies.
- VerificationFindings verified
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 23 cited sources checked · 0 supported · 0 flagged
- Findingown data
The mucosa of the oral cavity expresses ACE2.
“The results demonstrated that the ACE2 expressed on the mucosa of oral cavity.”
- Also stated in: § Public bulk RNA-seq dataset analysis · hedged
“According to the mean expression of ACE2, the mucosa of oral cavity could express ACE2, and the results were validated by the data of normal tissues from the FANTOM5 CAGE dataset (Fig. 1b).”
Quote in the paperSubstantial claim- Rests on an assumption: Public TCGA para-carcinoma normal tissues and FANTOM5 normal tissues are adequate proxies for normal oral mucosa.
- Rests on an assumption: The FANTOM5 CAGE dataset with only two tongue samples can validate ACE2 expression in the oral cavity.
- Also stated in: § Public bulk RNA-seq dataset analysis · hedged
- Findingown data
ACE2 can be expressed in various organs according to TCGA bulk RNA-seq.
“Fig. 1a showed that ACE2 could be expressed in various organs, the mean expression of different organs could be found in Table 1.”
Quote in the paperNot a substantial claim- Rests on an assumption: Public TCGA para-carcinoma normal tissues and FANTOM5 normal tissues are adequate proxies for normal oral mucosa.
- Interpretationown data
The oral cavity is a potentially high-risk site for 2019-nCoV infectious susceptibility.
“These findings indicated that oral cavity could be regarded as potentially high risk for 2019-nCov infectious susceptibility.”
- Also stated in: § Abstract · hedged
“Preliminarily, those findings have explained the basic mechanism that the oral cavity is a potentially high risk for 2019-nCoV infectious susceptibility”
Quote in the paperSubstantial claim- Rests on an assumption: ACE2 RNA expression levels in tissues indicate the presence of functional ACE2 receptor protein and susceptibility to 2019-nCoV infection.
- Also stated in: § Abstract · hedged
- Study design and conductcitation
The in-house tissues came from a previous project that found no significant expression difference among common epithelial markers in past and other studies.
“which from our previous project found no significant expression difference among the common epithelial markers in our past study and other previous study22–24.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [22] Dionne, K. R., Warnakulasuriya, S., Zain, R. B. & Cheong, S. C. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int. J. Cancer 136, 503–515 (2015). source
Not checked in the free run.
- cites [23] Li, J. et al. Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: evidence from cohort studies and functional analyses. EBioMedicine 2, 851–858 (2015). source
Not checked in the free run.
- cites [24] Wang, Z. et al. RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67. Eur. J. Cancer 45, 490–496 (2009). source
Not checked in the free run.
- Interpretationcitation
The relatively low ACE2 expression of lung in bulk RNA-seq datasets may be because ACE2 expression in lung is concentrated in a small population of type II alveolar cells.
“According to the study of Zhao et al.11, the ACE2 expression in lung is concentrated in a small population of type II alveolar cells (AT2), that may cause the relatively low ACE2 expression of lung in bulk-seq RNA datasets analysis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zhao et al.11 Zhao, Y. et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Preprint at https://www.biorxiv.org/content/10.1101/2020.01.26.919985v1 (2020).
Not checked in the free run.
- Premisecitation
Bulk data on ACE2 distribution cannot indicate cell type-specific expression.
“Previous studies have investigated the ACE2 mRNA and protein expression in various tissues by bulk samples17,18, however, the distribution of ACE2 through bulk data could not indicate the cell type-specific expression of ACE2.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [17] Harmer, D., Gilbert, M., Borman, R. & Clark, K. L. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 532, 107–110 (2002). source
Not checked in the free run.
- cites [18] Hamming, I. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631–637 (2004). source
Not checked in the free run.
- Premisecitation
Organs containing high ACE2-expressing cells should be considered potential high-risk sites for 2019-nCoV infection.
“These findings indicated that those organs with high ACE2-expressing cells should be considered as potential high risk for 2019-nCoV infection10.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Zou, X. et al. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front. Med. http://journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0 (2020). source
Not checked in the free run.
- Premisecitation
2019-nCoV does not use aminopeptidase N or dipeptidyl peptidase 4 as receptors.
“Zhou et al.4 also proved that 2019-nCoV does not use other coronavirus receptors, aminopeptidase N, and dipeptidyl peptidase 4.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zhou et al.4 Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. https://doi.org/10.1038/s41586-020-2012-7 (2020). source
Not checked in the free run.
- Premisecitation
The receptor-binding domain of the 2019-nCoV S-protein strongly interacts with human ACE2.
“The study of Xu et al.9 found that the RBD domain of the 2019-nCoV S-protein supports strong interaction with human ACE2 molecules.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xu et al.9 Xu, X. et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci. China Life Sci. https://doi.org/10.1007/s11427-020-1637-5 (2020). source
Not checked in the free run.
- Interpretationcitation
In addition to respiratory droplets and direct contact, fecal-oral transmission might also be a route of transmission of 2019-nCoV.
“Thus, our results support that in addition to the respiratory droplets and direct contact, fecal–oral transmission might also be the route of transmission of 2019-nCoV.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Guan, W.-J. et al. Clinical characteristics of 2019 novel coronavirus infection in China. Preprint at https://www.medrxiv.org/content/10.1101/2020.02.06.20020974v1 (2020).
Not checked in the free run.
- Rests on an assumption: ACE2 RNA expression levels in tissues indicate the presence of functional ACE2 receptor protein and susceptibility to 2019-nCoV infection.
- Interpretationreasoning
The ACE2 expression in the oral cavity means that an oral infection route of 2019-nCoV cannot be excluded.
“Likewise, although 2019-ncov infection hardly presented oral symptoms, the ACE2 expression in the oral cavity indicated that the oral infection route of 2019-nCoV cannot be excluded.”
Quote in the paperSubstantial claim- Rests on an assumption: ACE2 RNA expression levels in tissues indicate the presence of functional ACE2 receptor protein and susceptibility to 2019-nCoV infection.
- Rests on an assumption: 2019-nCoV infection hardly presents oral symptoms.
- May combine two claims. 18
- The quote only partly states this claim. 2
- Classified as probably not a substantial claim. 10
May combine two claims.
Findingown dataACE2 expression is higher in oral tongue than in buccal and gingival tissues, with 95.86% of ACE2-positive cells located in oral tongue.
“and higher in oral tongue than buccal and gingival tissues (95.86% ACE2-positive cells located in oral tongue).”
- Also stated in: § Discussion · boosted
“The results of our single cell RNA-seq profiles validated the ACE2 expression in oral cavity, and the level of ACE2 expression in oral tissues was higher in tongue than buccal or gingival tissues.”
Quote in the paperSubstantial claim- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
- Also stated in: § Discussion · boosted
May combine two claims. The quote only partly states this claim.
Findingown dataACE2 is highly enriched in epithelial cells, with 93.38% of ACE2-positive cells belonging to epithelial cells.
“and the ACE2 was highly enriched in epithelial cells, of which 93.38% ACE2-positive cells belong to epithelial cells (Fig. 2f).”
Quote in the paperSubstantial claim- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
May combine two claims.
Findingown dataACE2-positive cells in oral tissues include epithelial cells (1.19%), T cells (<0.5%), B cells (<0.5%), and fibroblasts (<0.5%).
“Figure 2e shows that the ACE2-positive cells could be found in oral tissues including epithelial cells (1.19% ACE2-positive cells), T cells (<0.5%), B cells (<0.5%), and fibroblast (<0.5%)”
- Also stated in: § Discussion · plain
“Interestingly, we found that the ACE2 also expressed in lymphocytes within oral mucosa, and similar results were found in various organs of the digestive system and in lungs11,12.”
Quote in the paperSubstantial claim- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
- Also stated in: § Discussion · plain
May combine two claims. The quote only partly states this claim.
Findingown dataSingle-cell RNA-seq of four oral tissues yielded 22,969 cells and identified seven cell types: epithelial cells, fibroblasts, T cells, macrophages, mast cells, B cells, and endothelial cells.
“After the data preprocessing (shown in section “Materials and methods”), 22 969 cells were acquired and 7 cell types were identified (Fig. 2a), including epithelial cells”
Quote in the paperSubstantial claim- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
May combine two claims.
Findingown dataIn TCGA adjacent normal oral tissues, mean ACE2 expression was higher in oral tongue than in other oral sites combined, but the difference was not statistically significant (P = 0.062).
“When we combined the base of tongue, floor of mouth and oral cavity as other sites, and compared them with oral tongue, we found the obvious tendency that the mean expression of ACE2 was higher in oral tongue (13 tissues) than others (19 tissues) (Fig. 1d), while may due to the limitation of the sample size, the p value was not significant (P = 0.062).”
Quote in the paperNot a substantial claim- Rests on an assumption: The TCGA site annotations for oral cavity samples are accurate.
May combine two claims.
Findingown dataACE2 is expressed in oral tissues, with 0.52% ACE2-positive cells.
“According to Fig. 2c, d, we confirmed the ACE2 was expressed in oral tissues (0.52% ACE2-positive cells)”
Quote in the paperSubstantial claim- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
May combine two claims.
Interpretationown dataACE2 is expressed on epithelial cells of the oral mucosa and is highly enriched in tongue epithelial cells.
“The above results indicated that the ACE2 could be expressed on the epithelial cells of the oral mucosa and highly enriched in tongue epithelial cells.”
- Also stated in: § Abstract · plain
“Interestingly, this receptor was highly enriched in epithelial cells of tongue.”
Quote in the paperSubstantial claim- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
- Also stated in: § Abstract · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe respiratory tract should also be considered a vulnerable target to 2019-nCoV infection.
“Even though, the result of Zou et al. indicated that the respiratory tract should also be considered as a vulnerable target to 2019-nCoV infection10.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Zou, X. et al. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front. Med. http://journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0 (2020). source
Not checked in the free run.
May combine two claims.
PremisecitationCells that express ACE2 can act as target cells and are susceptible to 2019-nCoV infection.
“These findings suggest that the ACE2 plays an important role in cellular entry, thus ACE2-expressing cells may act as target cells and are susceptible to 2019-nCoV infection10.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Zou, X. et al. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front. Med. http://journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0 (2020). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningACE2-expressing cells in oral tissues, especially tongue epithelial cells, might provide possible routes of entry for 2019-nCoV, indicating the oral cavity might be a potential risk route of infection.
“The ACE2-expressing cells in oral tissues, especially in epithelial cells of tongue, might provide possible routes of entry for the 2019-nCov, which indicate oral cavity might be a potential risk route of 2019-nCov infection.”
Quote in the paperSubstantial claim- Rests on an assumption: ACE2 RNA expression levels in tissues indicate the presence of functional ACE2 receptor protein and susceptibility to 2019-nCoV infection.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenRNA-seq data were batch effects normalized and log2-transformed.
“The RNA-seq data were batch effects normalized and log2-transformed for the subsequent analysis.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenSingle-cell data were normalized and confounding variation was removed using the sctransform function in Seurat.
“The “sctransform” wrapper in Seurat was applied to normalize the data and remove confounding sources of variation”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationACE2 also serves as the receptor for SARS-CoV and HCoV-NL63.
“Study of Zhou et al.4 indicated that the angiotensin-converting enzyme II (ACE2) is likely the cell receptor of 2019-nCoV, which were also the receptor for SARS-CoV and HCoV-NL637,8.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [7] Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450–454 (2003). source
Not checked in the free run.
- cites [8] Hofmann, H. et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl Acad. Sci. USA 102, 7988–7993 (2005). source
Not checked in the free run.
May combine two claims.
Study design and conductcitationThe in-house oral tissues were diagnosed as hyperkeratosis without dysplasia and their genetic profiles are closer to normal tissue than malignant tissue.
“The four were taken from three patients with an average age of 50, which were all diagnosed as hyperkeratosis without dysplasia by pathologists, just showing an increase in cell number in the spinous layer and/or in the basal/parabasal cell layers without cellular atypia, and its genetic profiles would be much more closed to normal tissue than malignant tissue22–24.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [22] Dionne, K. R., Warnakulasuriya, S., Zain, R. B. & Cheong, S. C. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int. J. Cancer 136, 503–515 (2015). source
Not checked in the free run.
- cites [23] Li, J. et al. Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: evidence from cohort studies and functional analyses. EBioMedicine 2, 851–858 (2015). source
Not checked in the free run.
- cites [24] Wang, Z. et al. RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67. Eur. J. Cancer 45, 490–496 (2009). source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationSingle-cell RNA-sequencing technology enables generation of transcriptomic data at cellular resolution.
“Recently developed single-cell RNA-sequencing technology enabled the generation of vast amounts of the transcriptomic data at cellular resolution19.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Rostom, R., Svensson, V., Teichmann, S. A. & Kar, G. Computational approaches for interpreting scRNA-seq data. FEBS Lett. 591, 2213–2225 (2017). source
Not checked in the free run.
May combine two claims.
PremisecitationACE2 is likely the cell receptor for 2019-nCoV and is important for viral entry into cells.
“Study of Zhou et al.4 indicated that the angiotensin-converting enzyme II (ACE2) is likely the cell receptor of 2019-nCoV, which were also the receptor for SARS-CoV and HCoV-NL637,8.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zhou et al.4 Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. https://doi.org/10.1038/s41586-020-2012-7 (2020). source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationHigh ACE2 expression has been found in several specific cell types across organs, including type II alveolar cells of lung, upper and stratified esophageal epithelial cells, absorptive enterocytes of ileum and colon, cholangiocytes, myocardial cells, kidney proximal tubule cells, and bladder urothelial cells.
“High ACE2 expression was identified in type II alveolar cells (AT2) of lung10–12, esophagus upper and stratified epithelial cells, absorptive enterocytes from ileum and colon12, cholangiocytes13, myocardial cells, kidney proximal tubule cells, and bladder urothelial cells10.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [10] Zou, X. et al. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front. Med. http://journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0 (2020). source
Not checked in the free run.
- cites [11] Zhao, Y. et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Preprint at https://www.biorxiv.org/content/10.1101/2020.01.26.919985v1 (2020).
Not checked in the free run.
- cites [12] Zhang, H. et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. Preprint at https://www.biorxiv.org/content/10.1101/2020.01.30.927806v1 (2020). source
Not checked in the free run.
- cites [13] Chai, X. et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. Preprint at https://www.biorxiv.org/content/10.1101/2020.02.03.931766v1 (2020). source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataCell types were assigned based on canonical markers.
“The uniform manifold approximation and projection (UMAP) was used for dimensionality reduction and clustering the cells, cell types were assigned based on their canonical markers.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataThe study's results are mainly based on public datasets and single-cell RNA-seq of in-house oral tissues with minimal diseased lesion.
“Our results are mainly based on public datasets and single cell RNA-sequencing data of in-house oral tissues with minimal diseased lesion”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningThe FANTOM5 CAGE dataset had only two tongue samples and was used to validate ACE2 expression in the oral cavity.
“as only two samples of this dataset which owns 60 samples in total located in the tongue, we just downloaded 14 organ types to validate the ACE2 expression in oral cavity with bar plot”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe ACE2 expression profile across organs, tissues, and cell types provides bioinformatics evidence for potential infection routes of 2019-nCoV and might be associated with presented symptoms.
“The ACE2 expression profile in various organs, tissues, and cell types, provides the bioinformatics evidence for the potential infection routes of 2019-nCov, which might also be associated with presented symptoms.”
Quote in the paperSubstantial claim- Rests on an assumption: ACE2 RNA expression levels in tissues indicate the presence of functional ACE2 receptor protein and susceptibility to 2019-nCoV infection.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenQuality control in single-cell RNA-seq removed cells with <200 genes and 500 UMI counts, cells with mitochondrial content >5%, and genes detected in <3 cells.
“To control quality, we removed cells with <200 genes and 500 UMI counts, and as well as the cells with mitochondrial content higher than 5%. Besides, the genes detected in <3 cells were filtered out.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
ACE2 RNA expression levels in tissues indicate the presence of functional ACE2 receptor protein and susceptibility to 2019-nCoV infection.
“The expression and distribution of the ACE2 in human body may indicate the potential infection routes of 2019-nCoV.”
The paper relies on this without support.
The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
“Single cell RNA-seq was utilized for four oral tissues, and the data was analyzed to confirm the above results and assess the cell type-specific expression of ACE2.”
The paper relies on this without support.
Public TCGA para-carcinoma normal tissues and FANTOM5 normal tissues are adequate proxies for normal oral mucosa.
“Bulk RNA-seq data of para-carcinoma normal tissues which were taken as control tissues in the studies were downloaded from The Cancer Genome Atlas (TCGA; https://www.cancer.gov/tcga), and 695 para-carcinoma normal tissues distributed in different organs were obtained for this study”
The paper relies on this without support.
The FANTOM5 CAGE dataset with only two tongue samples can validate ACE2 expression in the oral cavity.
“as only two samples of this dataset which owns 60 samples in total located in the tongue, we just downloaded 14 organ types to validate the ACE2 expression in oral cavity with bar plot”
The paper relies on this without support.
The TCGA site annotations for oral cavity samples are accurate.
“According to the site information provided by the TCGA, among the 32 adjacent normal tissues, 13 tissues located in the oral tongue, 2 tissues located in the base of tongue, 3 tissues located in the floor of mouse, and 14 tissues did not definite the site and were just put into the category of oral cavity.”
The paper relies on this without support.
2019-nCoV infection hardly presents oral symptoms.
“although 2019-ncov infection hardly presented oral symptoms”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The angiotensin-converting enzyme 2 receptor, which SARS-CoV-2 uses to bind and penetrate into cells, is widely expressed on the epithelial cells of the mucosa of the oral cavity.
“angiotensinconverting enzyme 2 receptor, which is used by SARS-CoV-2 to bind and penetrate into the cell, is widely expressed on the epithelial cells of the mucosa of the oral cavity [7].”
From Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study (2020) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
This check didn’t finish.
Cites
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209 · see citing works
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246 · see citing works
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244 · see citing works
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · see citing works
Self-citationWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148 · see citing works
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463 · see citing works
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907 · see citing works
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700 · see citing works
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · see citing works
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · see citing works
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510 · see citing works
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Chen, Y. Z., Liu, Q., & Guo, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25681 · Cited by 3,069 · see citing works
Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0754-0 · Cited by 2,287 · see citing works
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1637-5 · Cited by 2,206 · see citing works
A promoter-level mammalian expression atlas
The FANTOM Consortium and the RIKEN PMI and CLST (DGT) (2014) · Nature · doi:10.1038/nature13182 · Cited by 1,982 · see citing works
Clinical characteristics of 2019 novel coronavirus infection in ChinaPreprint
Guan, W., Ni, Z., Hu, Y., et al. (2020) · medRxiv · doi:10.1101/2020.02.06.20020974 · Cited by 1,485 · see citing works
Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection
Chai, X., Hu, L., Zhang, Y., Han, W., Lu, Z., Ke, A., Zhou, J., Shi, G., Fang, N., Fan, J., et al. (2020) · doi:10.1101/2020.02.03.931766 · Cited by 952 · see citing works
Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · doi:10.1101/2020.01.26.919985 · Cited by 860 · see citing works
Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
Harmer, D., Gilbert, M., Borman, R., & Clark, K. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03640-2 · Cited by 852 · see citing works
Hofmann, H., Pyrc, K., van der Hoek, L., Geier, M., Berkhout, B., & Pöhlmann, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409465102 · Cited by 824 · see citing works
Zhang, H., Kang, Z., Gong, H., Xu, D., Wang, J., Li, Z., Cui, X., Xiao, J., Meng, T., Zhou, W., et al. (2020) · doi:10.1101/2020.01.30.927806 · Cited by 658 · see citing works
Self-citationDionne, K. R., Warnakulasuriya, S., Binti Zain, R., & Cheong, S. C. (2015) · International Journal of Cancer · doi:10.1002/ijc.28754 · Cited by 248 · see citing works
Ren, X., Glende, J., Alfalah, M., de Vries, V., Schwegmann‐Weßels, C., Qu, X., Tan, L., Tschernig, T., Deng, H., Naim, H. Y., et al. (2006) · Journal of General Virology · doi:10.1099/vir.0.81749-0 · Cited by 192 · see citing works
Computational approaches for interpreting sc<scp>RNA</scp>‐seq data
Rostom, R., Svensson, V., Teichmann, S. A., & Kar, G. (2017) · FEBS Letters · doi:10.1002/1873-3468.12684 · Cited by 107 · see citing works
RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67
Wang, Z., Zhang, B., Jiang, L., Zeng, X., Chen, Y., Feng, X., Guo, Y., & Chen, Q. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.012 · Cited by 59 · see citing works
Self-citationLi, J., Feng, X., Sun, C., Zeng, X., Xie, L., Xu, H., Li, T., Wang, R., Xu, X., Zhou, X., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.07.004 · Cited by 38 · see citing works
Self-citationPeixoto, A. P., Campos, G. S., Queiroz, L. B., & Sardi, S. I. (2011) · Journal of Oral Science · doi:10.2334/josnusd.53.451 · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661 · see citing works
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360 · see citing works
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185 · see citing works
Features, Evaluation and Treatment Coronavirus (COVID-19)
Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Napoli, R. D. (2020) · StatPearls · Cited by 3,351 · see citing works
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
Tan, L., Wang, Q., Zhang, D., Jinya, D., Huang, Q., Wang, Q., Wang, Q., & Miao, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0148-4 · Cited by 1,684 · see citing works
Hematological findings and complications of COVID ‐19
Terpos, E., Ntanasis‐Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T. Ν., Politou, M., Ψαλτοπούλου, Θ., Gerotziafas, G., & Dimopoulos, M. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25829 · Cited by 1,716 · see citing works
Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
Dashraath, P., Wong, J. L. J., Lim, M. X. K., Lim, L. M., Li, S. W. L., Biswas, A., Choolani, M. A., Mattar, C. N. Z., & Su, L. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.03.021 · Cited by 1,459 · see citing works
Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., Rusconi, S., Gervasoni, C., Ridolfo, A. L., Rizzardini, G., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa330 · Cited by 1,326 · see citing works
Long covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655 · see citing works
Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0782-6 · Cited by 1,179 · see citing works
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Harrison, A. G., Lin, T., & Wang, P. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.10.004 · Cited by 1,177 · see citing works
Naqvi, A. A. T., Fatima, K., Mohammad, T., Fatima, U., Singh, I. K., Singh, A. K., Atif, S. M., Hariprasad, G., Hasan, G. M., & Hassan, M. I. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165878 · Cited by 1,118 · see citing works
SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells
Lukassen, S., Chua, R. L., Trefzer, T. B., Kahn, N. C., Schneider, M. A., Muley, T., Winter, H., Meister, M. A., Veith, C., Boots, A. W., et al. (2020) · The EMBO Journal · doi:10.15252/embj.20105114 · Cited by 1,082 · see citing works
Astuti, I., & Ysrafil, Y. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.020 · Cited by 1,067 · see citing works
Beyerstedt, S., Casaro, E. B., & Rangel, É. B. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04138-6 · Cited by 897 · see citing works
Proal, A. D., & VanElzakker, M. B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.698169 · Cited by 894 · see citing works
COVID-19, ACE2, and the cardiovascular consequences
South, A. M., Diz, D. I., & Chappell, M. C. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00217.2020 · Cited by 779 · see citing works
SARS-CoV-2 in wastewater: State of the knowledge and research needs
Kitajima, M., Ahmed, W., Bibby, K. J., Carducci, A., Gerba, C. P., Hamilton, K. A., Haramoto, E., & Rose, J. B. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139076 · Cited by 754 · see citing works
The oral microbiome: Role of key organisms and complex networks in oral health and disease
Sedghi, L., DiMassa, V., Harrington, A., Lynch, S. V., & Kapila, Y. L. (2021) · Periodontology 2000 · doi:10.1111/prd.12393 · Cited by 755 · see citing works
ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
Liu, F., Long, X., Zou, W., Fang, M., Wu, W., Li, W., Zhang, B., Zhang, W., Chen, X., & Zhang, Z. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.040 · Cited by 719 · see citing works
Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19)
Umakanthan, S., Sahu, P. K., Ranade, A. V., Bukelo, M. M., Rao, J. S., Abrahão‐Machado, L. F., Dahal, S., Kumar, H. D. V., & Kv, D. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138234 · Cited by 737 · see citing works
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
Abou-Ismail, M. Y., Diamond, A., Kapoor, S., Arafah, Y., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.06.029 · Cited by 694 · see citing works
Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
Huang, I., & Pranata, R. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00453-4 · Cited by 662 · see citing works
Possible aerosol transmission of COVID-19 and special precautions in dentistry
Ge, Z., Yang, L.-M., Xia, J., Fu, X.-H., & Zhang, Y. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2010010 · Cited by 706 · see citing works
COVID-19: Immunology and treatment options
Felsenstein, S., Herbert, J. A., McNamara, P. S., & Hedrich, C. M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108448 · Cited by 669 · see citing works
Immune determinants of COVID-19 disease presentation and severity
Brodin, P. (2021) · Nature Medicine · doi:10.1038/s41591-020-01202-8 · Cited by 654 · see citing works
Saliva is a reliable tool to detect SARS-CoV-2
Azzi, L., Carcano, G., Gianfagna, F., Grossi, P., Gasperina, D. D., Genoni, A. P., Fasano, M., Sessa, F., Tettamanti, L., Carinci, F., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.005 · Cited by 643 · see citing works
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
Malik, P., Patel, U. K., Mehta, D., Patel, N., Kelkar, R., Akrmah, M., Gabrilove, J. L., & Sacks, H. S. (2020) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111536 · Cited by 614 · see citing works
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Perico, L., Benigni, A., Casiraghi, F., Ng, L. F. P., Rénia, L., & Remuzzi, G. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00357-4 · Cited by 603 · see citing works
Catanzaro, M., Fagiani, F., Racchi, M., Corsini, E., Govoni, S. M., & Lanni, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0191-1 · Cited by 604 · see citing works
Multisystem inflammatory syndrome in children: A systematic review
Ahmed, M., Advani, S., Moreira, A., Zoretic, S., Martinez, J., Chorath, K. T., Acosta, S., Naqvi, R., Burmeister, F., Burmeister, F., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100527 · Cited by 603 · see citing works
Sardu, C., Gambardella, J., Morelli, M. B., Wang, X., Marfella, R., & Santulli, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051417 · Cited by 595 · see citing works
Acter, T., Uddin, N., Das, J., Akhter, A., Choudhury, T. R., & Kim, S. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138996 · Cited by 578 · see citing works
Aerosol transmission of SARS-CoV-2? Evidence, prevention and control
Tang, S., Mao, Y., Jones, R. M., Tan, Q., Ji, J. S., Li, N., Shen, J., Lv, Y., Pan, L., Ding, P., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.106039 · Cited by 552 · see citing works
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
Ozono, S., Zhang, Y., Ode, H., Sano, K., Tan, T. S., Imai, K., Miyoshi, K., Kishigami, S., Ueno, T., Iwatani, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21118-2 · Cited by 513 · see citing works
Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients
Lee, Y., Min, P., Lee, S., & Kim, S.-W. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e174 · Cited by 528 · see citing works
Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19
Zaid, Y., Puhm, F., Allaeys, I., Naya, A., Oudghiri, M., Khalki, L., Limami, Y., Zaïd, N., Sadki, K., Haj, R. B. E., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317703 · Cited by 499 · see citing works
Zoran, M. A., Savastru, R., Savastru, D. M., & Tautan, M. N. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139825 · Cited by 493 · see citing works
COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy
Izzetti, R., Nisi, M., Gabriele, M., & Graziani, F. (2020) · Journal of Dental Research · doi:10.1177/0022034520920580 · Cited by 485 · see citing works
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
Boettler, T., Newsome, P. N., Mondelli, M. U., Maticic, M., Cordero, E., Cornberg, M., & Berg, T. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100113 · Cited by 477 · see citing works
Devaux, C. A., Rolain, J., & Raoult, D. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.04.015 · Cited by 477 · see citing works
Ortiz-Prado, E., Simbaña-Rivera, K., Gómez- Barreno, L., Rubio-Neira, M., Guaman, L. P., Kyriakidis, N. C., Muslin, C., Jaramillo, A. M. G., Barba-Ostria, C., Cevallos-Robalino, D., et al. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115094 · Cited by 458 · see citing works
Chest CT in COVID-19: What the Radiologist Needs to Know
Kwee, T. C., & Kwee, R. M. (2020) · Radiographics · doi:10.1148/rg.2020200159 · Cited by 437 · see citing works
Kapila, Y. L. (2021) · Periodontology 2000 · doi:10.1111/prd.12398 · Cited by 423 · see citing works
COVID-19 and the elderly: insights into pathogenesis and clinical decision-making
Perrotta, F., Corbi, G., Mazzeo, G., Boccia, M., Aronne, L., D’Agnano, V., Komici, K., Mazzarella, G., Parrella, R., & Bianco, A. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01631-y · Cited by 419 · see citing works
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies
Feng, G., Zheng, K. I., Yan, Q., Rios, R. S., Targher, G., Byrne, C. D., Poucke, S. V., Liu, W., & Zheng, M. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00018 · Cited by 421 · see citing works
Current uses of chlorhexidine for management of oral disease: a narrative review
Brookes, Z. L. S., Bescós, R., Belfield, L., Ali, K., & Roberts, A. (2020) · Journal of Dentistry · doi:10.1016/j.jdent.2020.103497 · Cited by 441 · see citing works
Targeting the NLRP3 Inflammasome in Severe COVID-19
Freeman, T. L., & Swartz, T. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01518 · Cited by 406 · see citing works
Zhou, Z., Kang, H., Li, S., & Zhao, X. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09929-7 · Cited by 397 · see citing works
Pathophysiological mechanisms of liver injury in COVID‐19
Nardo, A. D., Schneeweiss‐Gleixner, M., Bakail, M., Dixon, E. D., Lax, S., & Trauner, M. (2020) · Liver International · doi:10.1111/liv.14730 · Cited by 394 · see citing works
Gemmati, D., Bramanti, B., Serino, M. L., Secchiero, P., Zauli, G., & Tisato, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103474 · Cited by 401 · see citing works
Saliva: potential diagnostic value and transmission of 2019-nCoV
Xu, R., Cui, B., Duan, X., Zhang, P., Zhou, X., & Yuan, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0080-z · Cited by 393 · see citing works
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)
Aleem, A., Samad, A., & Slenker, A. K. (2021) · Europe PMC (PubMed Central) · Cited by 398 · see citing works
Salivary Glands: Potential Reservoirs for COVID-19 Asymptomatic Infection
Jia, X., Li, Y., Gan, F., Du, Y., & Yao, Y. (2020) · Journal of Dental Research · doi:10.1177/0022034520918518 · Cited by 390 · see citing works
Fotuhi, M., Mian, A., Meysami, S., & Raji, C. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200581 · Cited by 388 · see citing works
Zhu, L., Yang, P., Zhao, Y., Zhuang, Z., Wang, Z., Song, R., Zhang, J., Liu, C., Gao, Q., Xu, Q., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.009 · Cited by 375 · see citing works
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States
Martines, R. B., Ritter, J. M., Matkovic, E., Gary, J. M., Bollweg, B. C., Bullock, H. A., Goldsmith, C. S., Silva-Flannery, L. M., Seixas, J. N., Reagan-Steiner, S., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2609.202095 · Cited by 375 · see citing works
Association between periodontitis and severity of COVID‐19 infection: A case–control study
Marouf, N., Cai, W., Said, K. N., Daas, H., Diab, H., Chinta, V. R., Hssain, A. A., Nicolau, B., Sanz, M., & Tamimi, F. (2021) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13435 · Cited by 380 · see citing works
Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms
Ahmadian, E., Khatibi, S. M. H., Soofiyani, S. R., Abediazar, S., Shoja, M. M., Ardalan, M., & Vahed, S. Z. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2176 · Cited by 366 · see citing works
Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?
dos Santos, J. A., Normando, A. G. C., da Silva, R. L. C., Paula, R. M. D., Cembranel, A. C. C., Santos‐Silva, A. R., & Guerra, E. N. S. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.012 · Cited by 362 · see citing works
Structural insights into SARS-CoV-2 proteins
Arya, R., Kumari, S., Pandey, B., Mistry, H., Bihani, S. C., Das, A., Prashar, V., Gupta, G. D., Panicker, L., & Kumar, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.11.024 · Cited by 351 · see citing works
Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection
Butowt, R., & von Bartheld, C. S. (2021) · The Neuroscientist · doi:10.1177/1073858420956905 · Cited by 345 · see citing works
Correlation of SARS-CoV-2 RNA in wastewater with COVID-19 disease burden in sewersheds
Weidhaas, J., Aanderud, Z. T., Roper, D. K., VanDerslice, J. A., Gaddis, E. J. B., Ostermiller, J., Hoffman, K., Jamal, R., Heck, P. E., Zhang, Y., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145790 · Cited by 345 · see citing works
COVID-19 and the Chemical Senses: Supporting Players Take Center Stage
Cooper, K. W., Brann, D. H., Farruggia, M. C., Bhutani, S., Pellegrino, R., Tsukahara, T., Weinreb, C., Joseph, P. V., Larson, E. D., Parma, V., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.032 · Cited by 335 · see citing works
Kirtsman, M., Diambomba, Y., Poutanen, S. M., Malinowski, A. K., Vlachodimitropoulou, E., Parks, W. T., Erdman, L. K., Morris, S. K., & Shah, P. S. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200821 · Cited by 334 · see citing works
Stanifer, M. L., Kee, C., Cortese, M., Metz‐Zumaran, C., Triana, S., Mukenhirn, M., Kraeusslich, H.-G., Alexandrov, T., Bartenschlager, R. F. W., & Boulant, S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107863 · Cited by 332 · see citing works
Extra-respiratory manifestations of COVID-19
Lai, C., Ko, W., Lee, P., Jean, S., & Hsueh, P. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106024 · Cited by 331 · see citing works
Wilson, N., Norton, A., Young, F., & Collins, D. W. (2020) · Anaesthesia · doi:10.1111/anae.15093 · Cited by 329 · see citing works
Jafarzadeh, A., Chauhan, P. S., Saha, B., Jafarzadeh, S., & Nemati, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118102 · Cited by 327 · see citing works
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
Salian, V. S., Wright, J. A., Vedell, P. T., Nair, S. A., Li, C., Kandimalla, M., Tang, X., Carmona, E. M., Kalari, K. R., & Kandimalla, K. K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00608 · Cited by 319 · see citing works
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Cuervo, N. Z., & Grandvaux, N. (2020) · eLife · doi:10.7554/elife.61390 · Cited by 306 · see citing works
Oral Manifestations in Patients with COVID-19: A Living Systematic Review
dos Santos, J. A., Normando, A. G. C., da Silva, R. L. C., Acevedo, A. C., Canto, G. D. L., Sugaya, N. N., Santos‐Silva, A. R., & Guerra, E. N. S. (2020) · Journal of Dental Research · doi:10.1177/0022034520957289 · Cited by 315 · see citing works
Potential effects of curcumin in the treatment of COVID ‐19 infection
Zahedipour, F., Hosseini, S. A., Sathyapalan, T., Majeed, M. A., Jamialahmadi, T., Al‐Rasadi, K., Banach, M., & Sahebkar, A. (2020) · Phytotherapy Research · doi:10.1002/ptr.6738 · Cited by 311 · see citing works
Lee, R. A., Herigon, J. C., Benedetti, A., Pollock, N. R., & Denkinger, C. M. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.02881-20 · Cited by 297 · see citing works
Sarin, S. K., Choudhury, A. K., Lau, G. K. K., Zheng, M., Ji, D., Abd-Elsalam, S. M., Hwang, J.-S., Qi, X., Cua, I. H., Suh, J. I., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10072-8 · Cited by 297 · see citing works
Potential fecal transmission of SARS-CoV-2: Current evidence and implications for public health
Amirian, E. S. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.04.057 · Cited by 294 · see citing works
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Ramasamy, S., & Subbian, S. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00299-20 · Cited by 291 · see citing works
Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19
Ahn, J. H., Kim, J., Hong, S. P., Choi, S. Y., Yang, M. J., Ju, Y. S., Kim, Y. T., Kim, H. M., Rahman, M. T., Chung, M. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148517 · Cited by 278 · see citing works
COVID-19: Characteristics and Therapeutics
Chilamakuri, R., & Agarwal, S. (2021) · Cells · doi:10.3390/cells10020206 · Cited by 283 · see citing works
Potential pathogenesis of ageusia and anosmia in COVID‐19 patients
Vaira, L. A., Salzano, G., Fois, A. G., Piombino, P., & RIU, G. D. (2020) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22593 · Cited by 283 · see citing works
Consolo, U., Bellini, P., Bencivenni, D., Iani, C., & Checchi, V. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103459 · Cited by 283 · see citing works
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594495 · Cited by 283 · see citing works
Detection of SARS‐CoV‐2 in saliva and characterization of oral symptoms in COVID‐19 patients
Chen, L., Zhao, J., Peng, J., Li, X., Deng, X., Geng, Z., Shen, Z., Guo, F., Zhang, Q., Jin, Y., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12923 · Cited by 274 · see citing works
Self-citationRheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
Misra, D. P., Agarwal, V., Gasparyan, A. Y., & Zimba, O. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05073-9 · Cited by 272 · see citing works
ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
Lee, I. T., Nakayama, T., Wu, C.-T., Goltsev, Y., Jiang, S., Gall, P. A., Liao, S. C., Shih, L., Schürch, C. M., McIlwain, D. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19145-6 · Cited by 253 · see citing works
COVID-19 faecal-oral transmission: Are we asking the right questions?
Heller, L., Mota, C. R., & Greco, D. B. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138919 · Cited by 262 · see citing works
Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression
Bohn, M. K., Hall, A., Sepiashvili, L., Jung, B., Steele, S., & Adeli, K. (2020) · Physiology · doi:10.1152/physiol.00019.2020 · Cited by 259 · see citing works
Wu, Y., Liu, C., Dong, L., Zhang, C., Chen, Y., Liu, J., Zhang, C., Duan, C., Zhang, H., Mol, B. W., et al. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16276 · Cited by 258 · see citing works
Datta, P., Liu, F.-M., Fischer, T., Rappaport, J., & Qin, X. (2020) · Theranostics · doi:10.7150/thno.48076 · Cited by 227 · see citing works
Obesity: A critical risk factor in the COVID ‐19 pandemic
Kwok, S., Adam, S., Ho, J. H., Iqbal, Z., Turkington, P. M., Razvi, S., le Roux, C. W., Soran, H., & Syed, A. A. (2020) · Clinical Obesity · doi:10.1111/cob.12403 · Cited by 257 · see citing works
Leung, C. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111255 · Cited by 250 · see citing works
What dentists need to know about COVID-19
Fini, M. B. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.104741 · Cited by 252 · see citing works
Gallo, O., Locatello, L. G., Mazzoni, A., Novelli, L., & Annunziato, F. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00359-2 · Cited by 246 · see citing works
Block, M. S., & Rowan, B. G. (2020) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2020.06.029 · Cited by 247 · see citing works
Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19
Khoury, M., Cuenca, J., Cruz, F. F., Figueroa, F. E., Rocco, P. R. M., & Weiss, D. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.00858-2020 · Cited by 243 · see citing works
Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation
Mehta, O. P., Bhandari, P., Raut, A. P., Kacimi, S. E. O., & Huy, N. T. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2020.582932 · Cited by 242 · see citing works
Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva
Iwasaki, S., Fujisawa, S., Nakakubo, S., Kamada, K., Yamashita, Y., Fukumoto, T., Sato, K., Oguri, S., Taki, K., Senjo, H., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.071 · Cited by 240 · see citing works
Microbiota Modulation of the Gut-Lung Axis in COVID-19
de Oliveira, G. L. V., Oliveira, C. N. S., Pinzan, C. F., de Salis, L. V. V., & Cardoso, C. R. D. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635471 · Cited by 238 · see citing works
Is the kidney a target of SARS-CoV-2?
Martínez-Rojas, M. A., Vega‐Vega, O., & Bobadilla, N. A. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00160.2020 · Cited by 231 · see citing works
Saliva as a Candidate for COVID-19 Diagnostic Testing: A Meta-Analysis
Czumbel, L. M., Kiss, S., Farkas, N., Mandel, I., Hegyi, A., Nagy, Á., Lohinai, Z. M., Szakács, Z., Hegyi, P. J., Steward, M. C., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00465 · Cited by 235 · see citing works
- Authors
- Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Li, Taiwen
- Venue
- International Journal of Oral Science
- Published
- 2020-02-24
- Volume
- 12
- Issue
- 1
- Pages
- 8-8
- ISSN
- 1674-2818 (ISSN-L)
- 2049-3169
- PMC
- PMC7039956
- OpenAlex
- W3008295344
- Cited by
- 2,838
- References
- 26
- Citations by year
- 2026: 32 · 2025: 59 · 2024: 136 · 2023: 287 · 2022: 469 · 2021: 846 · 2020: 1003 · 2019: 2 · 2018: 2 · 2015: 1
- FWCI
- 85.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Oral Science (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (111 Project, 81991502, B14038, 81771081, 81520108009, 81991500)
- Ministry of Education, India
- Higher Education Discipline Innovation Project (B14038)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Dentistry › General Dentistry › Dental Research and COVID-19
- Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
- Keywords
- ACE2 receptor, SARS-CoV-2, oral mucosa, host cell receptors, viral entry, infection susceptibility, single-cell transcriptomics, gene expression profiling, dental disease prevention
- MeSH terms
- Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Epithelial Cells, Humans, Peptidyl-Dipeptidase A, Mouth Mucosa, Pneumonia, Viral, Tongue, Coronavirus Infections, Gene Expression Profiling, Databases, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review